Evidence map›Paper›PMID 40488529›Full record

Observational studyThe Journal of infectious diseases2025

Decrease in Incidence of Diarrhea Due to Cryptosporidium in Bangladeshi Children Is Associated With an Increase in Anti-Cryptosporidium Antibody Avidity.

Carol A Gilchrist, William A O Petri, Biplob Hossain, Mamun Kabir, Hannah H So, G Brett Moreau, Uma Nayak, Jennie Z Ma, Zannatun Noor, Abu S G Faruque and 3 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02764918 (Field Studies of Cryptosporidiosis and Enteropathogens in Bangladesh), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02764918 active not recruitingnot on this map

Field Studies of Cryptosporidiosis and Enteropathogens in Bangladesh

TypeobservationalSponsorUniversity of VirginiaRan2024 to 2029Enrolled150ConditionsCryptosporidiosis
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Carol A GilchristDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0001-5027-1034
William A O PetriDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0009-0008-9045-6998
Biplob HossainLaboratory for Parasitology, International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh.ORCID 0000-0002-4934-9866
Mamun KabirLaboratory for Parasitology, International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh.
Hannah H SoDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.
G Brett MoreauDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0001-6032-4320
Uma NayakDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0003-0970-9262
Jennie Z MaDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-5839-2882
Zannatun NoorLaboratory for Parasitology, International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh.ORCID 0000-0002-9431-358X
Abu S G FaruqueLaboratory for Parasitology, International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh.
Masud AlamLaboratory for Parasitology, International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh.
Rashidul HaqueLaboratory for Parasitology, International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh.
William A PetriDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Funding

FIELD STUDIES OF IMMUNITY TO AMEBIASIS IN BANGLADESHR01AI043596 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CAROL A GILCHRIST, William A Petri · 1998 to 2026
$7.7M
Nanoformulation of Synergistic TLR Ligands to Enhance Amebiasis Vaccine EfficacyR21AI109118 · NIAID · ACCESS TO ADVANCED HEALTH INSTITUTE · PI FOX, CHRISTOPHER B · 2014 to 2015
$445k
Subunit Vaccine for CryptosporidiosisR21AI154862 · NIAID · UNIVERSITY OF VIRGINIA · PI PETRI, WILLIAM A · 2021 to 2022
$444k
Bill and Melinda Gates Foundation OPP1100514GACGovernment of the People's Republic of BangladeshNational Institute of Allergy and Infectious Diseases R01 AI-043596National Institute of Allergy and Infectious Diseases R21 AI-109118National Institute of Allergy and Infectious Diseases R21 AI-154862NIAID NIH HHS R01 AI043596NIAID NIH HHS R21 AI109118NIAID NIH HHS R21 AI154862SidaUKAid
6 · The paper itself

Abstract

backgroundCryptosporidium is a cause of diarrhea morbidity and mortality in infants in low- and middle-income countries.

methodsA cohort of children was followed longitudinally in a high-transmission-intensity community in Bangladesh.

resultsDiarrhea attributed to Cryptosporidium (cryptosporidiosis) decreased from a peak of 0.19 episodes per child at 1-2 years to 0.05 episodes per child at 3-4 years of age (P = .0064). Notably, the decrease in cryptosporidiosis was not accompanied by a decline in subclinical infections. Using an episode-based analysis confirmed that the parasite burden declined with repeated infections (P < .0001 from the mixed-effects model included data from all infection frequencies; Cq value of the first and fourth infections (last reinfection with >10 cases): Cq 28.65 ± 5.533 versus 32.42 ± 4.046). There was also a decrease in the time required to clear a parasitic infection: longer infections (>1 month) occurred in 43% of the first infections compared to 24% in the fourth infections (P = .00017 from the mixed-effects model). The avidity of anti-Cp23 and anti-Cp17 plasma IgG increased in older children who had fewer diarrheal infections (ratio of the avidity index after the first infection versus that in the older repeatedly infected children: 1.81 ± 1.02 for anti-Cp23 IgG P > .0001 and 1.14 ± 0.35 anti-Cp17 IgG P = .0056).

conclusionsOur results are consistent with the development of an anti-Cryptosporidium adaptive immune response over repeated infections (average number of previous infections at 4 years, 2.42 ± 1.24) characterized by an increase in anti-Cryptosporidium antibody avidity that is associated with a decrease in cryptosporidiosis but not in subclinical Cryptosporidium infections. Clinical Trials Registration. NCT02764918.

Indexed as

Antibodies, ProtozoanAntibody AffinityCryptosporidiosisCryptosporidiumDiarrheaBangladeshChild, PreschoolFemaleHumansImmunoglobulin GIncidenceInfantLongitudinal StudiesMaleAntibodies, ProtozoanImmunoglobulin Gantibody avidityCp17Cp23Cryptosporidiumhumoral immune response

Identifiers

PMID40488529
PMCPMC12455312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.